The Opportunity Assessment Group (OAG) provides a central resource for LifeArc, researching and analysing the potential of new and existing biomedical opportunities. The team performs detailed scientific assessments as well as analysis of competition and intellectual property (IP). OAG performs an essential role in helping to shape LifeArc’s portfolio including our Translational Challenges, in-house drug discovery and diagnostic projects and investment decisions by the Early Ventures teams as well as diligence to inform LifeArc’s broader strategic direction.

Success during this internship means that you will be able to effectively and efficiently apply established processes to manage diligence projects for OAG (therapeutics, diagnostics, other). This will involve carrying out scientific, technical, commercial and IP diligence according to predetermined Standard Operating Procedures. Diligence produced may have a direct influence on the company portfolio (Translational Challenges / Early Ventures).

You will be expected to interact credibly with leading experts, scientists and clinicians within academia and the pharmaceutical industry and to work collaboratively with other teams within LifeArc. Interns will work in teams with OAG Analysts and supported by Senior Analysts and/or Principals to deliver diligence or landscaping reports.

This is an ideal opportunity for someone who is considering working in translational science and a career path that would take them away from academic bench science.

Education & experience required:

Essential

• Recently completed or currently completing a PhD in life or medical sciences, or with equivalent experience
• Aptitude for describing complex scientific information in accessible terms and ability to quickly grasp new scientific concepts
• Well-developed written and oral communication skills
• Strong interpersonal skills with an ability to communicate confidently and effectively with academic staff, all levels of management and companies
• Competence in Word, Excel, PowerPoint and Outlook
• Self-starter

Desirable

• Experience in competitive intelligence, analysis and reporting
• Experience in science translation, including IP protection, commercialisation paths and funding models
• Understanding of the drug and/or diagnostic discovery process and of the academic, biotechnology and pharmaceutical industry marketplaces

Internship placement with an exciting and dynamic team within LifeArc

• Our standard internship length is three-months; however, we would consider a longer duration (up to a maximum 6 months) if it fits with the needs of the candidate and the OAG team.
• A high-quality training programme that would give you a baseline understanding of how to assess the scientific, commercial and intellectual property landscape around biomedical opportunities.
• Exposure to translational science in a commercial setting, allowing you to participate in decisions around investments, grant funding and drug/diagnostic development collaborations.
• Because we understand everyone has different requirements, our flexible benefits allow you to choose those which are important to you. Our pension scheme offers employer contributions of up to 12%, private health insurance, and annual leave of 31 days PLUS bank holidays.

Applications are now closed.

If your online application form is successful, you will be invited to complete a short strength-based video interview, known as Snapshot, during the week commencing 22nd April. Full instructions and guidance on how to approach and prepare for a strengths-based assessment will be provided before you complete the Snapshot.

Successful candidates will be invited to attend an in-person interview between 13 -24 May.

If you are currently completing a PhD we will require a letter of support from your PhD supervisor acknowledging that this will be a full time role and that you will not be participating in your PhD study during this internship – a Letter of Support template will be provided if your initial application is successful.